Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma

NCT00003568 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: gp100 antigen
BIOLOGICAL: incomplete Freund's adjuvant

Sponsor

University of Illinois at Chicago

Collaborators

[object Object]